Form 4 holding
EVP, Chief Scientific Officer
VERTEX PHARMACEUTICALS INC / MA
- Security class
- Common Stock
- Shares / value
- 34,477
- Estimated value
- $15,630,492
- Report date
- 22 Jan 2026
- Price
- $453.36
- Ownership
- Direct
David Altshuler - EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA
Issuer-level insider activity
- Role
- EVP, Chief Scientific Officer
- Issuer ticker
- VRTX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by David Altshuler since 05 Sep 2025
Reported holdings for David Altshuler in VERTEX PHARMACEUTICALS INC / MA
Transaction history for David Altshuler in VERTEX PHARMACEUTICALS INC / MA
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.